Ronald T. Borchardt, Ph.D.
Lawrence, KS
Advisor since 2015

I have very much enjoyed serving on RiverVest's Scientific Advisory Board. I have been very impressed with the quality of the companies in the firm’s investment portfolio, and the ability of the RiverVest team to identify investment opportunities and then guide their companies to become financially and scientifically successful.
Dr. Ronald T. Borchardt is Distinguished Professor Emeritus of Pharmaceutical Chemistry at The University of Kansas-Lawrence. Professor Borchardt’s contributions to the development and validation of cell cultures for studying drug transport across the intestinal mucosa and the blood-brain barrier have been particularly significant. His pioneering work led to the introduction of a cell culture model now widely used by scientists in pharmaceutical/biotechnology companies and in academic and government laboratories worldwide. As a medicinal chemist, who transitioned to biochemistry and pharmaceutical chemistry midway through his career in academia, Professor Borchardt also played a key role as a scientist, educator and consultant in the integration of drug discovery and development in pharmaceutical companies in the United States, Europe and Asia.
After earning a B.S. in Pharmacy from the University of Wisconsin-Madison in 1967 and a Ph.D. in Medicinal Chemistry from The University of Kansas-Lawrence in 1970, Professor Borchardt spent two years as a postdoctoral fellow at the National Institutes of Health. In 1971, he returned to his alma mater, The University of Kansas, as an Assistant Professor of Biochemistry and Medicinal Chemistry. Professor Borchardt was promoted through the ranks to the position of Solon E. Summerfield Distinguished Professor in 1981, a position that he held for 34 years until his retirement in 2015. From 1983 to 1998, he also served as chairman of the Department of Pharmaceutical Chemistry in the School of Pharmacy at The University of Kansas.
Throughout his academic career, Professor Borchardt has received numerous national and international awards and honors for his teaching and research accomplishments, including three honorary doctorate degrees from European universities.
Personal Interests: spending time with wife Pam at their home on White Sand Lake in northern Wisconsin
Committed to Doing Business the Right Way to Deliver the Best Outcomes for Patients, Entrepreneurs, and Investors
St. Louis, San Diego & Cleveland
Our Team
A Strong Partnership Built to Last

SchmelterCo-Founder & Managing Director

McKearnManaging Director

O'DonnellManaging Director

MelzerCo-Founder and Managing Director

HongManaging Director

RappManaging Director

SpilizewskiVice President

WeitzmanChief Financial Officer

ZikeSenior Associate

BermanConsultant and Venture Partner

RotherSenior Analyst

KleiboekerAnalyst

MesianoMarketing & Communications Specialist

KellerConsultant

SlavichController

CatheyDirector of Administration

ShortExecutive Assistant
Our Team
Scientific Advisors

BorchardtDistinguished Professor Emeritus

DiPersioChief, Division of Oncology and Deputy Director, Siteman Cancer Center, Washington University School of Medicine

PeckRetired Dean of the Washington University School of Medicine and the University’s Executive Vice Chancellor for Medical Affairs

RutterProfessor of Biochemistry and HHMI Investigator

TontonozFrancis and Albert Piansky Professor of Pathology, Professor of Biological Chemistry
15 Companies Founded
Collaborative Approach and Open Communication
An exceptional firm culture where each is expected to be transparent, strategic, dependable, results-driven, collaborative, and grounded in purpose. That's RiverVest.